Effects of Korean Red Ginseng Extract on Electrical Brain Activity in Elderly Subjects

NCT04167449 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-02-16

No results posted yet for this study

Summary

A prospective, randomized, double blind, placebo-controlled study to determine if a hydroponically-cultivated red ginseng preparation is superior to conventionally grown ginseng and placebo for positively affecting electrical activity of the brain during performance of various cognitive tasks.

Conditions

  • Brain Waves

Interventions

DIETARY_SUPPLEMENT

HRG80 Hydroponic Red Ginseng

Powdered root preparation of Panax ginseng standardized to 31.7 mg total ginsenosides

DIETARY_SUPPLEMENT

Conventional White Ginseng

Powdered root preparation of Panax ginseng standardized to 9.8 mg total ginsenosides

DIETARY_SUPPLEMENT

Placebo

Visually identical placebo capsule containing rice flour

Sponsors & Collaborators

  • EuroPharma, Inc.

    lead INDUSTRY

Principal Investigators

  • Wilfried Dimpfel, PhD · NeuroCode AG

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
60 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2020-03-30
Completion
2020-05-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04167449 on ClinicalTrials.gov